October 13, 2023
Executive Roundtable
44
10
Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.
October 13, 2023
Executive Profile
44
10
Stephen Rivera, vice president, global technical accounting advisory services and policy, Johnson & Johnson, capitalizes on his lively personality—and a courageous career journey—to bring people together to shape the future of biopharma.
October 13, 2023
Feature
44
10
Exploring the pharma and biotech financing, M&A, and stock market pictures through the first half of 2023—and implications for the future, as market challenges continue to weigh heavily in senior management decision-making.
October 12, 2023
Feature
44
10
A look at the intersection of rigorous compliance and ethical behavior: independent, charitable patient assistance foundations.
October 12, 2023
Columns
44
10
Payers won’t let these products break the bank.
October 12, 2023
Back Page
44
10
Clinical studies are increasingly designed to satisfy evidentiary needs.
October 11, 2023
Column
44
10
When you know it is coming—but it takes forever to get there.
October 11, 2023
Columns
44
10
How pharma companies can make justice and integrity a priority.
October 11, 2023
Feature
44
10
Effective engagement—from research to reimbursement—is key.
October 08, 2023
From the Editor
44
10
It’s with a heavy heart that I share my departure from Pharmaceutical Executive.® It’s hard to believe that one year ago (in September 2022) I began my journey with the team here and the publication (and with all of you!). First and foremost, a huge thank you to you, the reader, for trusting me to share content with you.
October 08, 2023
Issue PDF
44
10
Click the title above for a link to open the Pharmaceutical Executive October 2023 issue in an interactive PDF format.